Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral vaccination against pseudotuberculosis

E A Thornton1, G R Smith

  • 1Institute of Zoology, Zoological Society of London, UK.

Vaccine
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Measurements of the Deuteron-to-Proton F_{2} Structure-Function Ratio.

Physical review letters·2025
Same author

Aneurism of the Aorta.

Buffalo medical journal·2023
Same author

Measured proton electromagnetic structure deviates from theoretical predictions.

Nature·2022
Same author

Deeply Virtual Compton Scattering Cross Section at High Bjorken x_{B}.

Physical review letters·2022
Same author

Determination of the ^{27}Al Neutron Distribution Radius from a Parity-Violating Electron Scattering Measurement.

Physical review letters·2022
Same author

Form Factors and Two-Photon Exchange in High-Energy Elastic Electron-Proton Scattering.

Physical review letters·2022

Oral administration of Yersinia pseudotuberculosis strain M5 protects mice against virulent strains. This low-virulence oral vaccine candidate offers protection against homologous and heterologous Yersinia strains.

Area of Science:

  • Veterinary Microbiology
  • Immunology

Background:

  • Yersinia pseudotuberculosis causes disease in various animal species.
  • Understanding virulence and protective immunity is crucial for disease control.

Purpose of the Study:

  • To evaluate the immunoprotective potential of Yersinia pseudotuberculosis strain M5 against virulent homologous and heterologous strains.
  • To assess the efficacy of oral administration of strain M5 as a vaccine candidate.

Main Methods:

  • Mice were orally inoculated with Yersinia pseudotuberculosis strain M5.
  • Vaccinated mice were subsequently challenged with virulent Yersinia pseudotuberculosis strains.
  • Virulence, infection establishment, and lesion development were monitored.

Main Results:

Related Experiment Videos

  • Oral administration of strain M5 conferred significant protection against lethal oral challenge with virulent Yersinia pseudotuberculosis.
  • Strain M5 demonstrated protection against both homologous (serogroup IA) and heterologous (serogroup IA and IB) strains.
  • While lesions developed in vaccinated mice upon challenge, they frequently became sterile, indicating immune control.

Conclusions:

  • Yersinia pseudotuberculosis strain M5 is a promising candidate for oral immunization against yersiniosis.
  • The findings suggest potential applications for vaccinating feral and captive wild animals to prevent pseudotuberculosis.